THE BLOG
when to talk to your healthcare team about biomarker testing
because not all tumours behave the same way, biomarkers can provide information about the molecular characteristics of a tumour creating a personalized approach to treating cancer. knowing your biomarker status can determine if targeted therapies are right for you and...
why precision medicine matters
when we talk about mutations, this represents a very small amount of cancer patients - in colorectal cancer for example, mutations in NTRK, MSI-h/dMMR, and BRAF are considered rare [1%, 15%, 9% respectively]. however, this actually represents respectively-...
colorectal cancer canada survey results on molecular profiling in canada
@coloncanada through their GET PERSONAL program launched a two phase project- the first phase of the project included a The first phase of the project included a pan-tumour, pan-canadian survey that was sent to multi-disciplinary healthcare professionals aimed to...
the importance of biomarker testing
over the last two weeks we’ve shared lots of information about biomarkers and targeted therapies - but what does it all really mean? we wanted to show how important molecular profiling/biomarker testing is to guide treatment planning for patients. these graphics are...
let’s talk about biomarkers – BRAF
BRAF represents one of the most frequently mutated protein kinase genes in human tumours. BRAF mutation is seen in melanoma, papillary thyroid carcinoma [including papillary thyroid carcinoma arising from ovarian teratoma], ovarian serous tumours, colorectal...
let’s talk about biomarker – NTRK
neurotrophic tyrosine receptor kinase [NTRK] oncogenic NTRK gene fusions occur in many different tumour types. while present in a majority of certain rare tumours, such as secretory carcinoma of the breast or salivary gland and infantile fibrosarcoma, they are also...
Addressing long-term impacts of the pandemic on cancer care /via @globeandmail https://www.theglobeandmail.com/life/adv/article-addressing-long-term-impacts-of-the-pandemic-on-cancer-care/?utm_medium=Referrer:+Social+Network+/+Media&utm_campaign=Shared+Web+Article+Links